Technical Analysis for IQV - IQVIA Holdings, Inc.

Grade Last Price % Change Price Change
F 193.92 -0.24% -0.46
IQV closed up 1.59 percent on Wednesday, November 20, 2024, on 1.76 times normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
3 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down

Date Alert Name Type % Chg
Calm After Storm Range Contraction -0.24%
NR7 Range Contraction -0.24%
Lower Bollinger Band Walk Weakness -0.24%
Inside Day Range Contraction -0.24%
Lower Bollinger Band Touch Weakness -0.24%
Oversold Stochastic Weakness -0.24%
Slingshot Bearish Bearish Swing Setup 1.35%
Calm After Storm Range Contraction 1.35%
Lower Bollinger Band Walk Weakness 1.35%
Multiple of Ten Bullish Other 1.35%

   Recent Intraday Alerts

Alert Time
Down 1% 32 minutes ago
Rose Above Previous Day's High 43 minutes ago
Possible NR7 about 20 hours ago
Possible Inside Day about 20 hours ago
Up 1% about 24 hours ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

IQVIA Holdings, Inc. Description

IQVIA Holdings Inc., formerly Quintiles IMS Holdings, Inc., provides integrated information and technology-enabled healthcare services. The Company operates through segments, including Commercial Solutions; Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offerings include national information offerings, sub-national information offerings, technology solutions, and workflow analytics and consulting services. The Research & Development Solutions segment provides biopharmaceutical development services. It offers project management and clinical monitoring, clinical trial support services, Q2 solutions, and strategic planning and design. The Integrated Engagement Services segment offerings include healthcare provider engagement services, patient engagement services, and scientific strategy and medical affairs services. The Company has its operations in the Americas, Europe and Africa, and the Asia-Pacific.


Classification

Sector: Healthcare
Industry: Diagnostics & Research
Keywords: S&P 500 Life Sciences Technology Solutions Project Management Healthcare Service Biopharmaceutical Development Q2 Technology Enabled Healthcare Services

Is IQV a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 261.73
52 Week Low 187.62
Average Volume 1,503,401
200-Day Moving Average 231.82
50-Day Moving Average 224.22
20-Day Moving Average 209.35
10-Day Moving Average 205.14
Average True Range 7.25
RSI (14) 31.03
ADX 37.38
+DI 10.74
-DI 36.20
Chandelier Exit (Long, 3 ATRs) 209.60
Chandelier Exit (Short, 3 ATRs) 209.36
Upper Bollinger Bands 228.38
Lower Bollinger Band 190.31
Percent B (%b) 0.11
BandWidth 18.19
MACD Line -8.51
MACD Signal Line -6.62
MACD Histogram -1.8929
Fundamentals Value
Market Cap 35.47 Billion
Num Shares 183 Million
EPS 5.96
Price-to-Earnings (P/E) Ratio 32.61
Price-to-Sales 2.68
Price-to-Book 6.86
PEG Ratio 1.89
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 200.82
Resistance 3 (R3) 200.13 197.30 199.75
Resistance 2 (R2) 197.30 195.66 197.64 199.39
Resistance 1 (R1) 195.84 194.64 196.57 196.53 199.03
Pivot Point 193.00 193.00 193.37 193.35 193.00
Support 1 (S1) 191.54 191.36 192.27 192.23 189.73
Support 2 (S2) 188.71 190.35 189.05 189.37
Support 3 (S3) 187.25 188.71 189.01
Support 4 (S4) 187.94